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Abstract 
 
Chronic Obstructive Pulmonary Disease (COPD) is a major cause of disability and 
health care utilisation in Australia. The population prevalence is estimated at around 
10% but up to 80% may be unrecognised. Lack of early diagnosis reduces the 
opportunity for better management. Clinical practice guidelines were developed in 
the 1990’s to improve the diagnosis and management. The recommendation in the 
2003 Australian COPDX guidelines for case finding in primary care using 
spirometry in high-risk subjects was based on limited evidence. 
A preliminary qualitative-quantitative study of the attitudes of patients with 
(recognised) COPD and their general practitioners (GPs) to the disease and its 
diagnosis identified operational and behavioural barriers to earlier diagnosis, 
especially lack of access and expertise in spirometry among GPs. A cluster 
randomised crossover study was conducted over twelve months in eight practices in 
Southern Tasmania offering spirometry to smokers and ex-smokers aged over 35 
years. The study compared a model of opportunistic spirometry provision by visiting 
trained nurses (TN) with usual care (UC) where practices were provided with an 
electronic spirometer and spirometry training. Models were evaluated quantitatively 
for effectiveness, acceptability and utility in increasing the diagnosis of COPD, and 
qualitatively through focus groups with GPs. A longitudinal cohort of smokers was 
recruited in TN practices to assess the effect of feedback about normal or obstructive 
spirometry on smoking cessation and motivation to stop smoking using the 
Transtheoretical Model of stages. 
Spirometry provision in the TN model resulted in significantly more spirometry of 
high quality and testing in a greater proportion of the eligible population than the UC 
model. Although the TN model enabled recognition of substantial numbers of 
individuals with previously unrecognised obstruction, this did not translate into 
increased doctor-recorded diagnosis of COPD. Better practice systems for follow up, 
support for GPs in interpretation and realistic funding of spirometry are needed to 
achieve better outcomes from increased spirometry in primary care. Feedback to 
smokers with normal lung function was not associated with backward shift in stage 
of change but feedback on the presence of lung damage was associated forward shift 
in stage of change when allowing for smoking exposure. The odds of backward shift 
with feedback on lung damage, was related to pre-existing perceptions about poor 
lung health. 
 iii
Although spirometry is fundamental to making a diagnosis of COPD, provision 
through a model in primary care that delivers a high testing rate and high quality 
results will not increase diagnosis in the at-risk group without an effective protocol 
for appropriate action on results. 
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